Quest Diagnostics Inc's Cash & cash equivalent grew by 24.03 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Quest Diagnostics Inc's Quick Ratio to 0.49, above Quest Diagnostics Inc average Quick Ratio.

Within Medical Laboratories industry 23 other companies have achieved higher Quick Ratio than Quest Diagnostics Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 3470, from total ranking in the second quarter 2026 at 4089.

Explain Quick Ratio?
How much Cash & cash equivalents DGX�s has?
What are DGX�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/DGX/financial-strength

https://api.csimarket.com/api/v1/companies/DGX/fundamentals

https://api.csimarket.com/api/v1/companies/DGX/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

DGX Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	114 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	106.71 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.49	Subscribe	Subscribe	Subscribe	Subscribe
DGX's Total Ranking	# 3470	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	2.57 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	24.03 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 24
Healthcare Sector	# 743
Overall Market	# 2661

Quick Ratio Statistics
High	Average	Low
0.79	0.26	0.06
(Mar 31 2021)		(Sep. 30, 2011)

Financial Statements
Quest Diagnostics Inc's Current Liabilities	$ 1,834 Millions	Visit DGX's Balance sheet
Quest Diagnostics Inc's Cash & cash equivalent	$ 893 Millions	Visit DGX's Balance sheet
Source of DGX's Sales		Visit DGX's Sales by Geography

Cumulative Quest Diagnostics Inc's Quick Ratio

DGX's Quick Ratio for the trailling 12 Months

DGX Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	55.95 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	68.28 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.32	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 2930	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	14.47 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	22.56 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to DGX Financial Strength Comparisons >> Go to Compare DGX Quick Ratio to its Competitors

On the trailing twelve months basis DGX Cash & cash equivalent more than doubled by 106.71 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Quest Diagnostics Inc's Quick Ratio to 0.32, above DGX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 36 other companies have achieved higher Quick Ratio than Quest Diagnostics Inc. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending second quarter 2026 at 4090.

Explain Quick Ratio?
How much Cash & cash equivalents DGX�s has?
What are DGX�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 37
Healthcare Sector	# 909
Within the Market	#

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.65	0.25	0.1
(Mar 31 2021)		(June 30. 2012)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Laboratories Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Radnet Inc	1.11	$ 797.880 Millions	$ 716.642 Millions
Bioaffinity Technologies Inc	1.01	$ 2.550 Millions	$ 2.533 Millions
Quest Diagnostics Inc	0.49	$ 893.000 Millions	$ 1,834.000 Millions
Medpace Holdings Inc	0.47	$ 705.315 Millions	$ 1,496.097 Millions
Ge Healthcare Technologies Inc	0.32	$ 2,826.000 Millions	$ 8,815.000 Millions
Grail Inc	0.31	$ 29.394 Millions	$ 94.332 Millions
Iqvia Holdings Inc	0.31	$ 2,422.000 Millions	$ 7,777.000 Millions
Fortrea Holdings Inc	0.22	$ 220.600 Millions	$ 983.300 Millions
Charles River Laboratories International inc	0.18	$ 200.381 Millions	$ 1,089.258 Millions

Date modified: 2026-10-24T15:37:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.